No CrossRef data available.
Article contents
Problems arising after a new compound has shown proven activity in the laboratory
Published online by Cambridge University Press: 06 April 2009
Extract
Starting with the work showing activity in the research programme (Table 1), compounds will usually have been entered for various reasons, first into the in vitro testing systems, or more rarely into the in vivo system unless this is the only testing system available for that particular organism.
- Type
- Research Article
- Information
- Copyright
- Copyright © Cambridge University Press 1985
References
REFERENCES
Anon. (1983). Pharmaceutical innovation: recent trends, future prospects. Office of Health Economics, no. 74.Google Scholar
Anon. (1983). Safety requirements for the first use of drugs and diagnostic agents in man. Council for International Organizations of Medical Sciences, Geneva.Google Scholar
Anand, N., & Sen, A. B., (1983). Chemotherapy and Immunology on the Control of Malaria, Filariasis and Leishmaniasis. New Delhi: Tata and McGraw-Hill Publishing Co Ltd.Google Scholar
Anand, N., (1983). Molecules with restricted conformational mobility–an approach to drug design. Proceedings of the Indian National Science Academy 49, A(2) 233–55.Google Scholar
Rae, D. G., (1984). The development of a veterinary drug. Proceedings of the 3rd Pan-African Veterinary Congress,Khartoum October 1982 (in the Press).Google Scholar
Smith, G. T., (1983). The future for pharmaceuticals: the potential; the pattern and the problems. Office of Health Economics.Google Scholar